Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
説明 | SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK. |
別名 | SKLB163 |
分子量 | 405.92 |
分子式 | C18H16ClN3O2S2 |
CAS No. | 1255099-06-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (135.49 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SKLB-163 1255099-06-9 Apoptosis Cell Cycle/Checkpoint Cytoskeletal Signaling MAPK PI3K/Akt/mTOR signaling Proteases/Proteasome JNK Akt Caspase Rho SKLB 163 SKLB163 Inhibitor inhibitor inhibit